COMPANY INTELLIGENCE PROFILE
Immedica Pharma AB
pharmaceuticals
COMPANY OVERVIEW
About Immedica Pharma AB
orphan drugs, niche pharmaceuticals, emergency medicines, specialty pharmaceuticals, pharmaceutical manufacturing, rare diseases, commercialization services, market access, metabolic disorders, product from phase 2 to mature, pharmaceutical and medicine manufacturing, patient-centric approach, rare hematology & oncology, regulatory compliance, market expansion, patient focus, rare metabolic diseases, sustainability, rare disease collaborations, services, product lifecycle management, innovative treatments, b2b, pharmacovigilance, pharmaceutical commercialization, global distribution, rare disease pipeline, rare disease treatments, global healthcare access, partnerships, pharmaceutical, quality assurance, esg integration, healthcare innovation, medical affairs, niche therapies, oncology, healthcare, therapeutic areas, global healthcare, patient care, rare neurology, regulatory affairs, neurology therapies, clinical development, specialty care, oncology treatments, pharmaceuticals, supply chain management, medical devices, bioscience partnerships, distribution, medical, environmental services, renewables & environment, hospital & health care, health care, health, wellness & fitness, logistics & supply chain
Company information
TECHNOLOGY INTELLIGENCE